Bio-Techne Corp (TECH) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bio-techne Corp.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:04.858 Good morning, and welcome to the Biotechni earnings conference call for the first quarter 00:00:04.858 -- 00:00:07.601 of fiscal year 2026. 00:00:07.601 -- 00:00:12.348 At this time, all participants have been placed in a listen-only mode, and the call will 00:00:12.348 -- 00:00:16.434 be open for questions following management's prepared remarks. 00:00:16.434 -- 00:00:21.821 During our Q&A session, please limit yourself to one question and a follow-up. 00:00:21.821 -- 00:00:26.548 I would now like to turn the call over to David Clare, Biotechni's Vice President, Investor 00:00:26.548 -- 00:00:28.718 Relations. Please go ahead, sir. 00:00:28.718 -- 00:00:30.920 Good morning and thank you for joining us. 00:00:30.920 -- 00:00:35.824 On the call with me this morning are Kim Kelderman, President and Chief Executive Officer, 00:00:35.824 -- 00:00:39.827 and Jim Hippel, Chief Financial Officer of Biotechni. 00:00:39.827 -- 00:00:44.712 Before we begin, let me briefly cover our Safe Harbor Statement. 00:00:44.712 -- 00:00:48.715 Some of the comments made during this conference call may be considered forward-looking 00:00:48.715 -- 00:00:50.136 statements, 00:00:50.136 -- 00:00:54.900 including beliefs and expectations about the company's future results. 00:00:54.900 -- 00:00:58.587 The company's 10K for fiscal year 2025 00:00:58.587 -- 00:01:04.116 identify certain factors that could cause the company's actual results to differ materially 00:01:04.116 -- 00:01:08.563 from those projected in the forward-looking statements made during this call. 00:01:08.563 -- 00:01:13.030 The company does not undertake to update any forward-looking statements because of any 00:01:13.030 -- 00:01:16.735 new information or future events or developments. 00...